[go: up one dir, main page]

GR3026096T3 - Erythropoietin(EPO)-peptides and antibodies against them - Google Patents

Erythropoietin(EPO)-peptides and antibodies against them

Info

Publication number
GR3026096T3
GR3026096T3 GR980400264T GR980400264T GR3026096T3 GR 3026096 T3 GR3026096 T3 GR 3026096T3 GR 980400264 T GR980400264 T GR 980400264T GR 980400264 T GR980400264 T GR 980400264T GR 3026096 T3 GR3026096 T3 GR 3026096T3
Authority
GR
Greece
Prior art keywords
epo
antibodies
peptides
epitope
relates
Prior art date
Application number
GR980400264T
Other languages
English (en)
Inventor
Mathias Dr Fibi
Werner Dr Stueber
Original Assignee
Behring Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behring Diagnostics Gmbh filed Critical Behring Diagnostics Gmbh
Publication of GR3026096T3 publication Critical patent/GR3026096T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR980400264T 1989-07-26 1998-02-11 Erythropoietin(EPO)-peptides and antibodies against them GR3026096T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924746A DE3924746A1 (de) 1989-07-26 1989-07-26 Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper

Publications (1)

Publication Number Publication Date
GR3026096T3 true GR3026096T3 (en) 1998-05-29

Family

ID=6385895

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400264T GR3026096T3 (en) 1989-07-26 1998-02-11 Erythropoietin(EPO)-peptides and antibodies against them

Country Status (13)

Country Link
US (2) US5106954A (el)
EP (1) EP0410246B1 (el)
JP (1) JP3155002B2 (el)
KR (1) KR0175657B1 (el)
AT (1) ATE161577T1 (el)
AU (1) AU648506B2 (el)
CA (1) CA2021912C (el)
DE (2) DE3924746A1 (el)
DK (1) DK0410246T3 (el)
ES (1) ES2111524T3 (el)
GR (1) GR3026096T3 (el)
IE (1) IE902707A1 (el)
PT (1) PT94813B (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932968B1 (en) * 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB2270695B (en) * 1992-09-18 1996-06-05 Oxford Res Support Co Ltd Antibodies that activate plasminogen in the manner of streptokinase
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
EP1510524A3 (en) * 1995-06-07 2006-06-07 Ortho Pharmaceutical Corporation Compounds and peptides that bind to the erythropoietin receptor
KR100400637B1 (ko) * 1996-02-06 2004-03-10 씨제이 주식회사 생물학적으로유용한펩타이드
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
CN1280309C (zh) * 1997-12-03 2006-10-18 罗切诊断学有限公司 具有高比活的促红细胞生成素
US6831060B2 (en) 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
AU766507B2 (en) * 1999-05-07 2003-10-16 Genentech Inc. Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
KR100524041B1 (ko) * 1999-05-07 2005-10-27 제넨테크, 인크. 신규 침팬지 에리쓰로포이에틴 (chepo) 폴리펩티드 및 이를 코딩하는 핵산
US6703480B1 (en) 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
KR100785648B1 (ko) * 2000-04-05 2007-12-14 이종예 에리스로포이에틴 및 에리스로포이에틴 수용체의 검출
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2747325A1 (en) * 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
HUP0400703A3 (en) * 2001-02-06 2006-06-28 Merck Patent Gmbh Modified erythropoietin (epo) with reduced immunogenicity
WO2002070009A1 (fr) * 2001-02-27 2002-09-12 Yasuda, Yoshiko Medicaments preventifs/curatifs pour cicatrices hypertrophiques, cheloides et maladies arthritiques chroniques
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
ATE322498T1 (de) * 2001-07-26 2006-04-15 Tagra Biotechnologies Ltd Stabilisierte ascorbinsäure -3- phosphat- derivate
US6930086B2 (en) * 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
CA2471363C (en) * 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
CA2484556A1 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
JP2006515161A (ja) * 2002-08-09 2006-05-25 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング エリスロポエチンのｔ細胞エピトープ
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
US20070184519A1 (en) * 2003-04-02 2007-08-09 Shabnam Tangri Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US20040266993A1 (en) * 2003-06-30 2004-12-30 Evans Glen A. Non-immunoglobulin binding polypeptides
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
US20050255112A1 (en) * 2004-05-17 2005-11-17 Lee Jong Y Compositions and methods for preventing erythropoietin-associated hypertension
US7589063B2 (en) * 2004-12-14 2009-09-15 Aplagen Gmbh Molecules which promote hematopoiesis
KR20070092706A (ko) * 2004-11-10 2007-09-13 아플라겐 게엠베하 조혈을 촉진하는 분자
EA200701031A1 (ru) * 2004-11-10 2007-10-26 Аплаген Гмбх Молекулы, способствующие гематопоэзу
WO2006089228A2 (en) 2005-02-16 2006-08-24 Nektar Therapeutics Al, Corporation Conjugates of an epo moiety and a polymer
EP2377884A1 (en) 2005-05-10 2011-10-19 Neoloch Aps Neuritogenic peptides
EP1736481A1 (en) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietin variants
WO2006136450A2 (en) * 2005-06-23 2006-12-28 Aplagen Gmbh Supravalent compounds
PT2540309T (pt) * 2005-08-05 2017-12-29 Araim Pharmaceuticals Inc Péptidos protectores de tecidos e suas utilizações
BRPI0709014A2 (pt) * 2006-03-09 2011-06-21 Aplagen Gmbh moléculas modifcadas que promovem hematopoise
EP2134862A4 (en) * 2007-03-12 2011-04-20 Univ Utah Res Found COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT OF DIABETIC MICROVASCULAR COMPLICATIONS
WO2009094172A2 (en) * 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
NZ586947A (en) 2008-02-08 2012-11-30 Ambrx Inc Modified leptin polypeptides and their uses
CN107022020A (zh) 2008-09-26 2017-08-08 Ambrx公司 修饰的动物促红细胞生成素多肽和其用途
SI2928921T1 (sl) 2012-12-05 2021-05-31 Novartis Ag Sestavki in postopki za protitelesa, ki ciljajo epo
CN107922975B (zh) 2015-08-12 2022-06-28 诺华股份有限公司 治疗眼科病症的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4558005A (en) * 1982-09-13 1985-12-10 University Patents, Inc. Monoclonal anti-erythropoietin
US4558006A (en) * 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions

Also Published As

Publication number Publication date
IE902707A1 (en) 1991-02-27
US5106954A (en) 1992-04-21
CA2021912C (en) 2001-11-27
JPH0381294A (ja) 1991-04-05
PT94813B (pt) 1997-04-30
KR0175657B1 (ko) 1999-04-01
US5712370A (en) 1998-01-27
AU648506B2 (en) 1994-04-28
DK0410246T3 (da) 1998-08-31
DE3924746A1 (de) 1991-01-31
EP0410246B1 (de) 1997-12-29
CA2021912A1 (en) 1991-01-27
KR910002897A (ko) 1991-02-26
AU5977890A (en) 1991-01-31
ES2111524T3 (es) 1998-03-16
PT94813A (pt) 1991-03-20
JP3155002B2 (ja) 2001-04-09
EP0410246A1 (de) 1991-01-30
ATE161577T1 (de) 1998-01-15
DE59010787D1 (de) 1998-02-05

Similar Documents

Publication Publication Date Title
GR3026096T3 (en) Erythropoietin(EPO)-peptides and antibodies against them
GR3018773T3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods.
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
SG50681A1 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
EP0314402A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
GB2291059A (en) Papp-a,its immunodetection and uses
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
NO910209L (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer.
MX9803841A (es) Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.
OA09026A (en) Method for detecting antibodies to human immunodeficiency virus.
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
GR3007000T3 (el)
FR2615287B1 (fr) Micro-capteur a technologie integree pour la detection de la presence de certains gaz
DE69228739D1 (de) Immunoassay und monoklonaler antikörper zum nachweis von diarrhetischem schalentiergift
EP0553077A4 (en) Monoclonal antibodies to cyclodiene insecticides and method for detecting the same
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same
BR9305525A (pt) Teste de anticorpos para amilina
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
NO900092L (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.
IE882302L (en) Antigen fractions for detecting antibodies indicative of a¹cardiovascular risk
DK630189D0 (da) Fremgangsmaade og diagnosesaet til paavisning af antistoffer samt vandig vaskevaeske til brug herved
NO890775D0 (no) Apparat for testing av utblaasningssikring.
EP0332421A3 (en) Monoclonal antibodies recognizing human psti, hybridomas producing the same, and their preparation and use